Google Chrome
Safari
Firefox
Edge
News / Jul 23, 2021
Hovione signs the COP26 manifest to stop climate changes
BCSD Portugal, 23 July 2021
Search
Press Release / Aug 23, 2022
Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals
Hovione today announced an extension of collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field.
Press Release / Mar 18, 2024
Hovione and GEA Strengthen Partnership to Advance Continuous Tableting Technology
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally
Article / Oct 20, 2020
The Coronavirus Crisis: Challenges and Opportunities for CMOs, CDMOs and CROs
CheManager, 20 October 2020
Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Press Clipping / May 03, 2023
Hovione and Presspart extend technology partnership
Manufacturing Chemist, 3 May 2023
Devices
Hovione offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.
Press Clipping / Jun 21, 2021
Hovione meets increased demand during Covid
Irish Examiner, 21 june 2021